BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 4146850)

  • 1. Ventricular function curve analysis of the myocardial effects of three beta blockers.
    Smith RD; Nash CB
    Arch Int Pharmacodyn Ther; 1973 May; 203(1):151-63. PubMed ID: 4146850
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardioprotective effects of hydrolyzed bopindolol against contractile dysfunction produced by coronary stenosis and reperfusion in dogs.
    Noguchi K; Aniya Y; Ojiri Y; Chibana T; Matsuzaki T; Shiroma N; Fong KF; Uza M; Sakanashi M
    Arch Int Pharmacodyn Ther; 1994; 327(3):279-93. PubMed ID: 7848012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low dose beta-blocker prevents ovariectomy-induced bone loss in rats without affecting heart functions.
    Bonnet N; Benhamou CL; Malaval L; Goncalves C; Vico L; Eder V; Pichon C; Courteix D
    J Cell Physiol; 2008 Dec; 217(3):819-27. PubMed ID: 18727092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The action of propranolol on the dog heart.
    Harry JD; Linden RJ; Snow HM
    Br J Pharmacol; 1972 May; 45(1):155P-156P. PubMed ID: 4402822
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparative effects of sotalol and propranolol on myocardial contractility.
    Gomoll AW; Braunwald E
    Arch Int Pharmacodyn Ther; 1973 Oct; 205(2):338-54. PubMed ID: 4148833
    [No Abstract]   [Full Text] [Related]  

  • 6. Nutritional circulation in the heart. 3. Effect of isoproterenol and beta adrenergic blockade on myocardial hemodynamics and rubicium-86 extraction in the isolated supported heart preparation.
    Somani P; Laddu AR; Hardm HF
    J Pharmacol Exp Ther; 1970 Dec; 175(3):577-92. PubMed ID: 4395225
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of essential hypertension with combined vasodilation and beta-adrenergic blockade.
    Zacest R; Gilmore E; Koch-Weser J
    N Engl J Med; 1972 Mar; 286(12):617-22. PubMed ID: 4401216
    [No Abstract]   [Full Text] [Related]  

  • 8. The antiarrhythmic properties of UM-272, the dimethyl quaternary derivative of propranolol.
    Schuster DP; Lucchesi BR; Nobel NL; Mimnaugh MN; Counsell RE; Kniffen FJ
    J Pharmacol Exp Ther; 1973 Jan; 184(1):213-27. PubMed ID: 4405548
    [No Abstract]   [Full Text] [Related]  

  • 9. Role of vagus in the antagonism of ouabain induced arrhythmias in dogs by beta-adrenoceptor antagonists and related drugs.
    Alkondon M; Ray A; Sen P
    J Pharm Pharmacol; 1984 Oct; 36(10):702-4. PubMed ID: 6150094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical pharmacological effect of Soviet-made adrenergic beta receptor blockader Benzoral].
    Zamotaev IP; Lozinskiĭ LG; Sandomirskiĭ BL
    Kardiologiia; 1974 Aug; 14(8):93-7. PubMed ID: 4139305
    [No Abstract]   [Full Text] [Related]  

  • 11. Experimental treatment with beta blockers of hemodynamic and myocardial changes in organ donors.
    Ojeda-Rivero R; Hernández-Fernández A; Dominguez-Roldán JM; Calderón E; Ruiz M; Lage E; Ordoñez-Fernandez A
    Transplant Proc; 2002 Feb; 34(1):185-6. PubMed ID: 11959241
    [No Abstract]   [Full Text] [Related]  

  • 12. Reappraisal of inotropic variations induced by bilateral carotid occlusion in dogs submitted to betablock with propranolol.
    Cicogna AC; Spadaro J; Tucci PJ
    Arq Bras Cardiol; 1978 Feb; 31(1):7-12. PubMed ID: 26321
    [No Abstract]   [Full Text] [Related]  

  • 13. Antiarrhythmic and general cardiovascular activity of the N,N-dimethylquaternary ammonium derivative of bunolol.
    Kaplan HR; Barker JW; Dugan D; Fox J; Giardino E
    Arch Int Pharmacodyn Ther; 1974 Jan; 207(1):28-43. PubMed ID: 4151048
    [No Abstract]   [Full Text] [Related]  

  • 14. Hemodynamic effects of 4-(3,4-dimethoxybenzyl)-2-imidazolidinone (Ro 7-2956): a nonadrenergic myocardial stimulant.
    Osborne MW; Wenger JJ; Moe RA
    J Pharmacol Exp Ther; 1971 Jan; 176(1):174-83. PubMed ID: 4398214
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluation of alpha-adrenergic cardiac stimulation in anesthetized dogs: can this play a role in propranolol insensitive cardiostimulatory effects of celiprolol.
    Jolly SR; Smith RD; Wolf PS; Russ TP
    Res Commun Chem Pathol Pharmacol; 1986 Dec; 54(3):339-54. PubMed ID: 2879327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The haemodynamic and myocardial contractile effects of celiprolol, atenolol and propranolol in mecamylamine-verapamil pretreated, anaesthetised dogs.
    Smith RD; Barrett JA; Wolf PS; Pruss TP
    Br J Clin Pract Suppl; 1985 Jun; 42():35-43. PubMed ID: 2864075
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparative potency of intravenous penbutolol and propranolol in man.
    Sharma PL; Sapru RP
    Int J Clin Pharmacol Biopharm; 1978 Feb; 16(2):83-5. PubMed ID: 24597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the anti-arrhythmic action and beta-blocking potency of LB 46 and (--)-propranolol.
    Flórez J; Arconada JA
    Arch Int Pharmacodyn Ther; 1971 Mar; 190(1):199-207. PubMed ID: 4396347
    [No Abstract]   [Full Text] [Related]  

  • 19. Selective beta adrenergic receptor antagonism in the anesthetized dog.
    Wasserman MA; Levy B
    J Pharmacol Exp Ther; 1974 Feb; 188(2):357-67. PubMed ID: 4149462
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of beta-adrenoceptor blocking drugs on the chronotropic and inotropic actions of isoprenaline on the acutely denervated dog heart.
    Harry JD; Kappagoda CT; Linden RJ; Snow HM
    Br J Pharmacol; 1971 Feb; 41(2):387P-389P. PubMed ID: 4396704
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.